Accelerate Approval Of Novel Therapies

The landscape of clinical development is in constant flux. Despite promising new therapies, the industry faces the challenge of tackling ever-more intricate diseases, which demand equally intricate solutions.

Under the dual pressures of securing regulatory approval and instilling hope in patients, teams are tasked with overcoming the common hurdles strewn along the discovery-to-approval path. Consider this: the development of a single therapy can cost between $1 billion to $2 billion, yet a mere 12% of medications ever make it to regulatory approval and market launch. Thus, every decision in the clinical trial journey carries profound significance.

Equipped with robust information, the choices team makes become the linchpin of success, calling on publications and regulatory submissions for pivotal million-dollar verdicts and access to patient-level data from recent trials for insights into increasingly specific patient populations.

The end goal is ultimately rapid progress and cost-efficiency in crafting secure, impactful treatments. Learn how to make critical, data-driven decisions throughout the product development lifecycle and increase your probability of success with Medidata Trial Design.